We use cookies to enhance your browsing experience, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Learn more in our Cookie Policy.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
Dive into our resources - including research publications that highlight our innovative approach, the latest news on Genomate's advancements, and inspiring success stories from patients, oncologists, and partners.
A 43-year-old female was diagnosed in July 2020 with localized Human Epidermal Growth Factor Receptor 2 (HER2) positive, Estrogen Receptor/Progesterone Receptor (ER/PR) positive grade III invasive carcinoma of the left breast.
